Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis

Cancer Letters

Volumn 333, Issue 1, 2013, Pages 113-123

  Rathore, Kusum ^a,b   Wang, Hwa Chain Robert ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Breast cell carcinogenesis; Cancer stem like cells; Epithelial to mesenchymal transition; Intervention of carcinogenesis; Low dose carcinogens

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ALDEHYDE DEHYDROGENASE; BENZO[A]PYRENE; CATECHIN; CELL MARKER; GRAPE SEED EXTRACT;

ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL RENEWAL; CELL SIZE; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; PRIORITY JOURNAL; TUMOR PROMOTION;

BENZO(A)PYRENE; BREAST NEOPLASMS; CATECHIN; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GRAPE SEED EXTRACT; HUMANS; NITROSAMINES; PROANTHOCYANIDINS; STEM CELLS; TEA;

VITACEAE;

EID: 84876082216     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.030     Document Type: Article

References (72)

1. Guengerich F.P. Metabolism of chemical carcinogens. Carcinogenesis 2000, 21:345-351.
2. Kelloff G.J., Hawk E.T., Sigman C.C. Cancer Chemoprevent. 2005, 2. Human Press, New Jersey, Totowa.
3. DeBruin L.S., Josephy P.D. Perspectives on the chemical etiology of breast cancer. Environ. Health Perspect. 2002, 1:119-128.
4. Hecht S.S. Tobacco smoke carcinogens and breast cancer. Environ. Mol. Mutagen. 2002, 39:119-126.
5. Roukos D.H., Murray S., Briasoulis E. Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol. Ther. 2007, 6:308-312.
6. Mehta R.G. Experimental basis for the prevention of breast cancer. Eur. J. Cancer 2000, 36:1275-1282.
7. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999, 91:1194-1210.
8. Obana H., Hori S., Kashimoto T., Kunita N. Polycyclic aromatic hydrocarbons in human fat and liver. Bull. Environ. Contam. Toxicol. 1981, 27:23-27.
9. Hecht S.S., Carmella G., Chen M., Dor Koch J.F., Miller A.T., Murphy S.E., Jensen J.A., Zimmerman C.L., Hatsukami D.K. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 1999, 59:590-596.
10. Besaratinia A., Maas E.M., Brouwer E.J., De Moonen T.M., Kok G.J., Wesseling S., Loft J.C., Kleinjans F.J.Van., Schooten A. Molecular dosimetry approach to assess human exposure to environmental tobacco smoke in pubs. Carcinogenesis 2003, 23:1171-1176.
11. Mei J., Hu H., McEntee M., Song P., Wang H.C.R. Transformation of noncancerous human breast epithelial cell MCF10A induced by the tobacco-specific carcinogen NNK. Breast Cancer Res. Treat. 2003, 79:95-105.
12. Siriwardhana N., Wang H.C.R. Precancerous carcinogenesis of human breast epithelial cells by chronic exposure to benzo[a]pyrene. Mol. Carcinogen. 2008, 47:338-348.
13. Siriwardhana N., Choudhary S., Wang H.C.R. Precancerous model of human breast epithelial cells induced by the tobacco-specific carcinogen NNK for prevention. Breast Cancer Res. Treat. 2008, 109:427-441.
14. Song X., Siriwardhana N., Rathore K., Wang H.C.R. Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Mol. Carcinogen. 2010, 49:450-463.
15. Rathore K., Choudhary S., Odoi A., Wang H.C.R. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 2012, 33:174-183.
16. Rathore K., Wang H.C.R. Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens. Mol. Carcinogen. 2012, 51:280-289.
17. Hecht S.S. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco specific lung carcinogen. Crit. Rev. Toxicol. 1996, 26:163-181.
18. Hecht S.S., Hatsukami D.K., Bonilla L.E., Hochalter J.B. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine, a substantial pathway of nicotine metabolism. Chem. Res. Toxicol. 1999, 12:172-179.
19. Chhabra S.K., Anderson L.M., Perella C., Desai D., Amin S., Kyrtopoulos S.A., Souliotis V.L. Coexposure to ethanol with N-nitrosodimethylamine or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during lactation of rats, marked increase in O(6)-methylguanine-DNA adducts in maternal mammary gland and in suckling lung and kidney. Toxicol. Appl. Pharmacol. 2000, 169:191-200.
20. Ohnishi T., Fukamachi K., Ohshima Y., Jiegou X., Ueda S., Iigo M., Takasuka N., Naito A., Fujita K., Matsuoka Y., Izumi K., Tsuda H. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens. Toxicol. Pathol. 2007, 35:436-443.
21. Cavalieri E., Rogan E., Sinha D. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J. Cancer Res. Clin. Oncol. 1988, 114:3-9.
22. Li A., Zhang W., Sahin A.A., Hittelman W.N. DNA adducts in normal tissue adjacent to breast cancer, a review. Cancer Detect. Prev. 1999, 23:454-462.
23. Rundle A., Tang D., Hibshoosh H., Estabrook A., Schnabel F., Cao W., Grumet S., Perera F.P. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 2000, 21:1281-1289.
24. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke, a bio-historical perspective with updates. Carcinogenesis 2011, 22:1903-1930.
25. Reynolds P., Hurley S., Goldberg D.E., Anton-Culver H., Bernstein L., Deapen D., Horn-Ross P.L., Peel D., Pinder R., Ross R.K., West D., Wright W.E., Ziogas A. Active smoking, household passive smoking, and breast cancer, evidence from the California Teachers Study. J. Natl. Cancer Inst. 2004, 96:29-37.
26. Johnson K.C., Miller A.B., Collishaw N.E., Palmer J.R., Hammond S.K., Salmon A.G., Cantor K.P., Miller M.D., Boyd N.F., Millar J., Turcotte F. Active smoking and secondhand smoke increase breast cancer risk, the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tobacco Control. 2011, 20:e2.
27. Reynolds P., Goldberg D., Hurley S., Nelson D.O., Largent J., Henderson K.D., Bernstein L. Passive smoking and risk of breast cancer in the California teachers study. Cancer Epidemiol., Biomarkers Prevent. 2009, 18:3389-3398.
28. Iwasaki M., Tsugane S. Risk factors for breast cancer, epidemiological evidence from Japanese studies. Cancer Sci. 2011, 102:1607-1614.
29. Sadri G., Mahjub H. Passive or active smoking, which is more relevant to breast cancer. Saudi Med. J. 2007, 28:254-258.
30. Kavanagh K.T., Hafer L.J., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., Sonenshein G.E. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem. 2001, 82:387-398.
31. Roomi M.W., Roomi N.W., Ivanov V., Kalinovsky T., Niedzwiecki A., Rath M. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague- Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res. 2005, 7:291-295.
32. Kim H., Hall P., Smith M., Kirk M., Prasain J.K., Barnes S., Grubbs C. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J. Nutr. 2004, 134:3445S-3452S.
33. Farnie G., Clarke R.B. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev. 2007, 3:169-175.
34. Charafe-Jauffret E., Monville E., Ginestier C., Dontu G., Birnbaum D., Wicha M.S. Cancer stem cells in breast, current opinion and future challenges. Pathobiology 2008, 75:75-84.
35. Kakarala M., Wicha M.S. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J. Clin. Oncol. 2008, 26:2813-2820.
36. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
37. Lipton A., Klinger I., Paul D., Holley R.W. Migration of mouse 3T3 fibroblasts in response to a serum factor. Proc. Natl. Acad. Sci. USA 1977, 11:2799-2801.
38. Choudhary S., Sood S., Donnell R.L., Wang H.C.R. Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 2012, 33:876-885.
39. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47:3239-3245.
40. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
41. Ginestier A., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1:555-567.
42. Duong M.T., Akli S., Wei C., Wingate H.F., Liu W., Lu Y., Yi M., Mills G.B., Hunt K.K., Keyomarsi K. LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients. PLoS Genet. 2012, 8:e1002538.
43. ImageJ. Image Processing and Analysis in Java. http://rsbweb.nih.gov/ij/.
44. Simes R.J. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986, 73:751-754.
45. Marshall C.J., Franks L.M., Carbonell A.W. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J. Natl. Cancer Inst. 1977, 58:1743-1751.
46. Hanahan A., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
47. Campisi J., Morreo G., Pardee A.B. Kinetics of G1 transit following brief starvation for serum factors. Exp. Cell Res. 1984, 152:459-466.
48. Larsson O., Zetterberg A., Engstrom W. Consequences of parental exposure to serum-free medium for progeny cell division. J. Cell Sci. 1985, 75:259-268.
49. Valentijn A.J., Zouq N., Gilmore A.P. Anoikis. Biochem. Soc. Trans. 2004, 32:421-425.
50. Reddig P.J., Juliano R.L. Clinging to life, cell to matrix adhesion and cell survival. Cancer Metast. Rev. 2005, 24:425-439.
51. Datta S., Hoenerhoff M.J., Bommi P., Sainger R., Guo W.J., Dimri M., Band H., Band V., Green J.E., Dimri G.P. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res. 2007, 67:10286-10295.
52. Choudhary S., Rathore K., Wang H.C.R. FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death. Anticancer Drugs 2010, 21:831-840.
53. Al-Hajj M., Wicha M.S., Benito-Hernandez A. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
54. Cioce M., Gherardi S., Viglietto G., Strano S., Blandino G., Muti P., Ciliberto G. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 2010, 9:2878-2887.
55. Engelmann K., Shen H., Finn O.J. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 2008, 68:2419-2426.
56. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., Hur M.H., Diebel M.E., Monville F, Dutcher J., Brown M., Viens P., Xerri L., Bertucci F., Stassi G., Dontu G., Birnbaum D., Wicha M.S. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009, 69:1302-1313.
57. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2002, 2:442-454.
58. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition, new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
59. Liu M., Casimiro M.C., Wang C., Shirley L.A., Jiao X., Katiyar S., Ju X., Li Z., Yu Z., Zhou J., Johnson M., Fortina P., Hyslop T., Windle J.J., Pestell R.G. P21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl. Acad. Sci. USA 2009, 106:19035-19039.
60. Wijnhoven B.P., Dinjens W.N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Brit. J. Surg. 2000, 87:992-1005.
61. Litvinov S.V., Balzar M., Winter M.J., Bakker H.A., Briaire-de Bruijn I.H., Prins F., Fleuren G.J., Warnaar S.O. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J. Cell Biol. 1997, 139:1337-1348.
62. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
63. Vuoriluoto K., Haugen H., Kiviluoto S., Mpindi J.P., Nevo J., Gjerdrum C., Tiron C., Lorens J.B., Ivaska J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30:1436-1448.
64. Dimri G., Band H., Band V. Mammary epithelial cell transformation, insights from cell culture and mouse models. Breast Cancer Res. 2005, 7:171-179.
65. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
66. De Mejia E.G., Ramirez-Mares M.V., Puangpraphant S. Bioactive components of tea: cancer, inflammation and behavior. Brain Behav. Immun. 2009, 23:721-731.
67. Jayabalan R., Subathradevi B., Marimuthu S., Sathishkumar M., Swaminathan K. Changes in free-radical scavenging ability of kombucha tea during fermentation. Food Chem. 2008, 109:227-234.
68. Thakur V.S., Gupta K., Gupta S. The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr. Pharm. Biotechnol. 2012, 13:191-199.
69. Sabisz M., Skladanowski A. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. Curr. Pharm. Biotechnol. 2008, 9:325-336.
70. Norton R., O'Connell M.A. Vitamin D: potential in the prevention and treatment of lung cancer. Anticancer Res. 2012, 32:211-221.
71. Cavaliere C., Foglia P., Gubbiotti R., Sacchetti P., Samperi R., Laganà A. Rapid-resolution liquid chromatography/mass spectrometry for determination and quantitation of polyphenols in grape berries. Rapid Commun. Mass Spectrom. 2008, 22:3089-3099.
72. Shiraishi M., Fujishima H., Chijiwa H. Evaluation of table grape genetic resources for sugar, organic acid, and amino acid composition of berries. Eupytica 2010, 174:1-13.